Fig. 12

PAD1 and PAD2 with two representative compounds (top). Below, pharmacophore 1 corresponding to a combination of PAD1 and PAD2 (left) and pharmacophore 2 (with ponatinib) derived from the nine compounds fitting pharmacophore 1